Inventor · disambiguated record
Mark T. Bilodeau
Also filed as: BILODEAU MARK T
60 granted patents·44 pending applications·1,736 citations·filing 1995–2025
99Inventor score
Files withTARVEDA THERAPEUTICS INC29MERCK & CO INC22PLACON THERAPEUTICS INC16MERCK SHARP & DOHME8BILODEAU MARK T7
Top patents by PatentIndex Score
104 records- 0198US6306874B1Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2000·Granted Oct 23, 2001·214 cites·36 claims
- 0298US6245759B1Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2000·Granted Jun 12, 2001·197 cites·3 claims
- 0397US6794393B1Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2000·Granted Sep 21, 2004·75 cites·3 claims
- 0496US6875767B2(5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Apr 5, 2005·87 cites·7 claims
- 0596US6586423B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Jul 1, 2003·151 cites·8 claims
- 0696US6162804ATyrosine kinase inhibitorsMERCK & CO INC·Filed 1999·Granted Dec 19, 2000·164 cites·21 claims
- 0795US6586424B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Jul 1, 2003·95 cites·8 claims
- 0895US6544988B1Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2000·Granted Apr 8, 2003·81 cites·13 claims
- 0995US6465484B1Angiogenesis inhibitorsMERCK & CO INC·Filed 1999·Granted Oct 15, 2002·144 cites·14 claims
- 1093US6235741B1Angiogenesis inhibitorsMERCK & CO INC·Filed 1998·Granted May 22, 2001·73 cites·3 claims
- 1193US5859041ASubstituted imidazoles having cytokine inhibitory activityMERCK & CO INC·Filed 1997·Granted Jan 12, 1999·135 cites·24 claims
- 1292US7223738B2Inhibitors of Akt activityMERCK & CO INC·Filed 2003·Granted May 29, 2007·38 cites·9 claims
- 1391US7655649B2Inhibitors of Akt activityMERCK SHARP & DOHME·Filed 2005·Granted Feb 2, 2010·20 cites·8 claims
- 1491US6958340B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Oct 25, 2005·73 cites·12 claims
- 1588US9556214B2Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2013·Granted Jan 31, 2017·7 cites·2 claims
- 1687US9750818B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2016·Granted Sep 5, 2017·6 cites·2 claims
- 1787US7544677B2Inhibitors of Akt activityMERCK & CO INC·Filed 2005·Granted Jun 9, 2009·13 cites·7 claims
- 1886US10624967B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·2 cites·8 claims
- 1985US8003643B2Inhibitors of Akt activityMERCK SHARP & DOHME·Filed 2009·Granted Aug 23, 2011·7 cites·8 claims
- 2085US7750151B2Inhibitors of Akt activityMERCK SHARP & DOHME·Filed 2005·Granted Jul 6, 2010·10 cites·2 claims
- 2184US9403858B2Platinum compounds, compositions, and uses thereofPLACON THERAPEUTICS INC·Filed 2015·Granted Aug 2, 2016·5 cites·12 claims
- 2283US7115597B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2003·Granted Oct 3, 2006·19 cites·31 claims
- 2382US10322191B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·3 cites·5 claims
- 2482US10287308B2Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2017·Granted May 14, 2019·1 cites·20 claims
- 2580US10548881B2HSP90 targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Feb 4, 2020·1 cites·32 claims
- 2679US11241500B2HSP90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Feb 8, 2022·1 cites·19 claims
- 2779US10111853B2Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·1 cites·19 claims
- 2879US6380203B1Angiogenesis inhibitorsMERCK & CO INC·Filed 1998·Granted Apr 30, 2002·24 cites·14 claims
- 2978US9738672B2Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2014·Granted Aug 22, 2017·1 cites·14 claims
- 3078US7125888B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2003·Granted Oct 24, 2006·12 cites·7 claims
- 3177US9937187B2Platinum compounds, compositions, and uses thereofPLACON THERAPEUTICS INC·Filed 2016·Granted Apr 10, 2018·2 cites·20 claims
- 3277US8252799B2Hexahydro-1H-4,7-methanoisoindole-1,3-dione compoundsBILODEAU MARK T·Filed 2008·Granted Aug 28, 2012·2 cites·8 claims
- 3377US7910561B2Inhibitors of Akt activityMERCK SHARP & DOHME·Filed 2005·Granted Mar 22, 2011·3 cites·4 claims
- 3477US7304063B2Inhibitors of Akt activityMERCK & CO INC·Filed 2004·Granted Dec 4, 2007·10 cites·11 claims
- 3577US2022185836A1Compounds, compositions, and methods for the treatment of cancersXLINK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3676US7879839B2Potassium channel inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Feb 1, 2011·2 cites·5 claims
- 3776US2020121808A1Sstr-targeted conjugates encapsulated in particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3874US10322137B2Platinum compounds, compositions, and uses thereofPLACON THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·1 cites·7 claims
- 3974US10011622B2Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2014·Granted Jul 3, 2018·1 cites·14 claims
- 4074US7638530B2Inhibitors of Akt activityMERCK & CO INC·Filed 2004·Granted Dec 29, 2009·7 cites·5 claims
- 4174US6090789ASynthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereofSLOAN KETTERING INST CANCER·Filed 1997·Granted Jul 18, 2000·20 cites·13 claims
- 4273US8829196B2TRPA1 antagonistsBILODEAU MARK T·Filed 2010·Granted Sep 9, 2014·3 cites·12 claims
- 4373US7579355B2Inhibitors of Akt activityMERCK & CO INC·Filed 2004·Granted Aug 25, 2009·7 cites·13 claims
- 4473US6872724B2Polymorphs with tyrosine kinase activityMERCK & CO INC·Filed 2003·Granted Mar 29, 2005·3 cites·7 claims
- 4573US2022288229A1Targeted conjugates encapsulated in particles and formulations thereofTVA ABC LLC·Filed 2022·Application pending·0 cites
- 4672US8389720B2Quinolone neuropeptide S receptor antagonistsBARROW JAMES C·Filed 2009·Granted Mar 5, 2013·1 cites·8 claims
- 4771US8592425B2Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitorsALTMAN MICHAEL D·Filed 2010·Granted Nov 26, 2013·2 cites·17 claims
- 4871US8410111B2Hexahydro-1H-4,7-methanoisoindole-1,3-dione compoundsBILODEAU MARK T·Filed 2012·Granted Apr 2, 2013·1 cites·8 claims
- 4970US11510910B2HSP90 targeted conjugates and particles and formulations thereofTVA ABC LLC·Filed 2019·Granted Nov 29, 2022·0 cites·19 claims
- 5070US2019218241A1Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 104 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →